Day One Biopharmaceutical Bolsa (NASDAQ: DAWN)

Day One Biopharmaceutical (NASDAQ:DAWN) Bolsa, Quote.MetaTitle.unusual-options

Day One Biopharmaceutical

Day One Biopharmaceuticals, Inc. - Common Stock

Panorámica general

Noticias

Beneficios

Opciones

Calificaciones de analistas

Operaciones de insiders

Interés en corto

Informe de acciones

Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, and kinase inhibitor.

Comments

Day One Biopharmaceutical Opciones Inusuales

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL